Dieter Hubmann is an experienced leader in the pharmaceutical industry, currently serving as Vice President and Head of Region Western Europe at medac GmbH since May 2023, while also heading medac Switzerland. In addition, Dieter Hubmann owns HubMar GmbH since August 2022 and previously held significant positions, including Managing Board Member and Co-Lead of the Market Access Task Force at vips Vereinigung Pharmafirmen in der Schweiz until September 2023. Dieter Hubmann's previous experience includes General Manager at Fresenius Kabi (Schweiz) AG from August 2005 to June 2022, where responsibilities encompassed being a local Board Member and President. Additional roles included Sales Director at Pharma Plan Bergauer + Partner AG, Project Leader at Schering-Plough, Business Unit Manager at Essex Chemie AG, and various sales and management positions at Bristol-Myers Squibb. Dieter Hubmann holds a Medizinalchemie degree from the University of Basel and has further education from St. Galler Business School.